⌘K

Login Start Free

Home/Filings/4/0001209191-21-042300

4//SEC Filing

Salter Malcolm 4

Accession 0001209191-21-042300

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 8:23 PM ET

Size

4.7 KB

Accession

0001209191-21-042300

Insider Transaction Report

Form 4

Period: 2021-06-18

C4 Therapeutics, Inc.CCCC

Director

Transactions

Sale
Common Stock
2021-06-18$37.19/sh−755$28,078→ 14,843 total

Footnotes (1)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001825124

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 8:23 PM ET
Size: 4.7 KB

View on SEC.gov